NOPAIN for Veterans Act
Sponsored By: Representative Landsman, Greg [D-OH-1]
In Committee
Summary
Guarantees VA will add FDA‑approved non‑opioid pain drugs to its national formulary for veterans. This bill would define those drugs as FDA‑approved treatments that reduce postoperative pain or provide postsurgical or regional analgesia without acting on opioid receptors and set clear deadlines for VA to add them.
Show full summary
- Veterans and families: Would expand access to FDA‑approved non‑opioid postoperative and regional pain treatments, giving more options to manage pain without opioids.
- VA providers and the VA system: Would require the Secretary of Veterans Affairs to add eligible drugs to the VA national formulary and the VA drug standardization list within 90 days after enactment, and to add any drug that later becomes eligible for certain Medicare payment statuses within one year of that eligibility.
- Funding oversight: Bars using funds from the Cost of War Toxic Exposures Fund to carry out these changes.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
More non-opioid pain drugs for veterans
If enacted, the bill would require VA to add certain FDA‑cleared non‑opioid drugs and biologicals for postoperative or regional pain to its national formulary. The rule defines qualifying products as FDA approved, granted, or cleared for postoperative or postsurgical/regional analgesia that do not act on opioid receptors. VA would have to include a qualifying product in its formulary within one year after that product becomes eligible for certain Medicare payment rules, and the Secretary must implement the bill's changes within 90 days of enactment. The bill would bar using money from the Cost of War Toxic Exposures Fund to carry out these changes.
Sponsors & CoSponsors
Sponsor
Landsman, Greg [D-OH-1]
OH • D
Cosponsors
Rep. Van Orden, Derrick [R-WI-3]
WI • R
Sponsored 7/17/2025
Rep. Pappas, Chris [D-NH-1]
NH • D
Sponsored 7/17/2025
Rep. Bergman, Jack [R-MI-1]
MI • R
Sponsored 7/17/2025
Sewell
AL • D
Sponsored 7/17/2025
Rep. Hamadeh, Abraham J. [R-AZ-8]
AZ • R
Sponsored 7/17/2025
Khanna
CA • D
Sponsored 7/25/2025
Rep. Stanton, Greg [D-AZ-4]
AZ • D
Sponsored 10/3/2025
Rep. Suozzi, Thomas R. [D-NY-3]
NY • D
Sponsored 10/8/2025
Craig
MN • D
Sponsored 10/8/2025
Rep. Pettersen, Brittany [D-CO-7]
CO • D
Sponsored 10/31/2025
Rep. Morrison, Kelly [D-MN-3]
MN • D
Sponsored 11/7/2025
Del. Norton, Eleanor Holmes [D-DC-At Large]
DC • D
Sponsored 11/21/2025
McBride
DE • D
Sponsored 12/1/2025
Kennedy (NY)
NY • D
Sponsored 12/5/2025
Ciscomani
AZ • R
Sponsored 12/9/2025
DelBene
WA • D
Sponsored 12/11/2025
Schmidt
KS • R
Sponsored 12/19/2025
Rep. Harrigan, Pat [R-NC-10]
NC • R
Sponsored 1/12/2026
Rep. Thanedar, Shri [D-MI-13]
MI • D
Sponsored 1/22/2026
Rep. Morelle, Joseph D. [D-NY-25]
NY • D
Sponsored 2/11/2026
Rep. Vindman, Eugene Simon [D-VA-7]
VA • D
Sponsored 2/23/2026
Rep. Kiggans, Jennifer A. [R-VA-2]
VA • R
Sponsored 2/26/2026
Rep. Tran, Derek [D-CA-45]
CA • D
Sponsored 3/5/2026
Rep. Goodlander, Maggie [D-NH-2]
NH • D
Sponsored 3/26/2026
Rep. Fitzpatrick, Brian K. [R-PA-1]
PA • R
Sponsored 4/2/2026
Rep. Bynum, Janelle S. [D-OR-5]
OR • D
Sponsored 4/23/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov